# PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

> **NCT00380263** · NA · COMPLETED · sponsor: **Danish Headache Center** · enrollment: 12 (actual)

## Conditions studied

- Migraine Without Aura

## Interventions

- **DRUG:** PACAP38

## Key facts

- **NCT ID:** NCT00380263
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2008-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380263, "PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00380263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*